Neutropenia Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014531382
Market Monitor Global
Oct-2021
Life Sciences
93 Pages

This report contains market size and forecasts of Neutropenia Drugs in global, including the following market information:
Global Neutropenia Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Neutropenia Drugs Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Neutropenia Drugs companies in 2020 (%)
The global Neutropenia Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neutropenia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neutropenia Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Neutropenia Drugs Market Segment Percentages, By Type, 2020 (%)
Capsule
Injection

Global Neutropenia Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Neutropenia Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic

Global Neutropenia Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Neutropenia Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neutropenia Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Neutropenia Drugs revenues share in global market, 2020 (%)
Key companies Neutropenia Drugs sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Neutropenia Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Apotex Inc.
Biogenomics Limited
Cellerant Therapeutics, Inc.
Coherus BioSciences, Inc.
Dr. Reddy's Laboratories Limited
Ligand Pharmaceuticals, Inc.
NAL Pharmaceuticals Ltd.
Prolong Pharmaceuticals, LLC
Richter Gedeon Nyrt.
Sandoz International GmbH

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Neutropenia Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neutropenia Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neutropenia Drugs Overall Market Size
2.1 Global Neutropenia Drugs Market Size: 2021 VS 2027
2.2 Global Neutropenia Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Neutropenia Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Neutropenia Drugs Players in Global Market
3.2 Top Global Neutropenia Drugs Companies Ranked by Revenue
3.3 Global Neutropenia Drugs Revenue by Companies
3.4 Global Neutropenia Drugs Sales by Companies
3.5 Global Neutropenia Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Neutropenia Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Neutropenia Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neutropenia Drugs Players in Global Market
3.8.1 List of Global Tier 1 Neutropenia Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Neutropenia Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neutropenia Drugs Market Size Markets, 2021 & 2027
4.1.2 Capsule
4.1.3 Injection
4.2 By Type - Global Neutropenia Drugs Revenue & Forecasts
4.2.1 By Type - Global Neutropenia Drugs Revenue, 2016-2021
4.2.2 By Type - Global Neutropenia Drugs Revenue, 2022-2027
4.2.3 By Type - Global Neutropenia Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Neutropenia Drugs Sales & Forecasts
4.3.1 By Type - Global Neutropenia Drugs Sales, 2016-2021
4.3.2 By Type - Global Neutropenia Drugs Sales, 2022-2027
4.3.3 By Type - Global Neutropenia Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Neutropenia Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neutropenia Drugs Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Neutropenia Drugs Revenue & Forecasts
5.2.1 By Application - Global Neutropenia Drugs Revenue, 2016-2021
5.2.2 By Application - Global Neutropenia Drugs Revenue, 2022-2027
5.2.3 By Application - Global Neutropenia Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Neutropenia Drugs Sales & Forecasts
5.3.1 By Application - Global Neutropenia Drugs Sales, 2016-2021
5.3.2 By Application - Global Neutropenia Drugs Sales, 2022-2027
5.3.3 By Application - Global Neutropenia Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Neutropenia Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Neutropenia Drugs Market Size, 2021 & 2027
6.2 By Region - Global Neutropenia Drugs Revenue & Forecasts
6.2.1 By Region - Global Neutropenia Drugs Revenue, 2016-2021
6.2.2 By Region - Global Neutropenia Drugs Revenue, 2022-2027
6.2.3 By Region - Global Neutropenia Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Neutropenia Drugs Sales & Forecasts
6.3.1 By Region - Global Neutropenia Drugs Sales, 2016-2021
6.3.2 By Region - Global Neutropenia Drugs Sales, 2022-2027
6.3.3 By Region - Global Neutropenia Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Neutropenia Drugs Revenue, 2016-2027
6.4.2 By Country - North America Neutropenia Drugs Sales, 2016-2027
6.4.3 US Neutropenia Drugs Market Size, 2016-2027
6.4.4 Canada Neutropenia Drugs Market Size, 2016-2027
6.4.5 Mexico Neutropenia Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Neutropenia Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Neutropenia Drugs Sales, 2016-2027
6.5.3 Germany Neutropenia Drugs Market Size, 2016-2027
6.5.4 France Neutropenia Drugs Market Size, 2016-2027
6.5.5 U.K. Neutropenia Drugs Market Size, 2016-2027
6.5.6 Italy Neutropenia Drugs Market Size, 2016-2027
6.5.7 Russia Neutropenia Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Neutropenia Drugs Market Size, 2016-2027
6.5.9 Benelux Neutropenia Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Neutropenia Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Neutropenia Drugs Sales, 2016-2027
6.6.3 China Neutropenia Drugs Market Size, 2016-2027
6.6.4 Japan Neutropenia Drugs Market Size, 2016-2027
6.6.5 South Korea Neutropenia Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Neutropenia Drugs Market Size, 2016-2027
6.6.7 India Neutropenia Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Neutropenia Drugs Revenue, 2016-2027
6.7.2 By Country - South America Neutropenia Drugs Sales, 2016-2027
6.7.3 Brazil Neutropenia Drugs Market Size, 2016-2027
6.7.4 Argentina Neutropenia Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neutropenia Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Neutropenia Drugs Sales, 2016-2027
6.8.3 Turkey Neutropenia Drugs Market Size, 2016-2027
6.8.4 Israel Neutropenia Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Neutropenia Drugs Market Size, 2016-2027
6.8.6 UAE Neutropenia Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Apotex Inc.
7.1.1 Apotex Inc. Corporate Summary
7.1.2 Apotex Inc. Business Overview
7.1.3 Apotex Inc. Neutropenia Drugs Major Product Offerings
7.1.4 Apotex Inc. Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Apotex Inc. Key News
7.2 Biogenomics Limited
7.2.1 Biogenomics Limited Corporate Summary
7.2.2 Biogenomics Limited Business Overview
7.2.3 Biogenomics Limited Neutropenia Drugs Major Product Offerings
7.2.4 Biogenomics Limited Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Biogenomics Limited Key News
7.3 Cellerant Therapeutics, Inc.
7.3.1 Cellerant Therapeutics, Inc. Corporate Summary
7.3.2 Cellerant Therapeutics, Inc. Business Overview
7.3.3 Cellerant Therapeutics, Inc. Neutropenia Drugs Major Product Offerings
7.3.4 Cellerant Therapeutics, Inc. Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Cellerant Therapeutics, Inc. Key News
7.4 Coherus BioSciences, Inc.
7.4.1 Coherus BioSciences, Inc. Corporate Summary
7.4.2 Coherus BioSciences, Inc. Business Overview
7.4.3 Coherus BioSciences, Inc. Neutropenia Drugs Major Product Offerings
7.4.4 Coherus BioSciences, Inc. Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Coherus BioSciences, Inc. Key News
7.5 Dr. Reddy's Laboratories Limited
7.5.1 Dr. Reddy's Laboratories Limited Corporate Summary
7.5.2 Dr. Reddy's Laboratories Limited Business Overview
7.5.3 Dr. Reddy's Laboratories Limited Neutropenia Drugs Major Product Offerings
7.5.4 Dr. Reddy's Laboratories Limited Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Dr. Reddy's Laboratories Limited Key News
7.6 Ligand Pharmaceuticals, Inc.
7.6.1 Ligand Pharmaceuticals, Inc. Corporate Summary
7.6.2 Ligand Pharmaceuticals, Inc. Business Overview
7.6.3 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Major Product Offerings
7.6.4 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Ligand Pharmaceuticals, Inc. Key News
7.7 NAL Pharmaceuticals Ltd.
7.7.1 NAL Pharmaceuticals Ltd. Corporate Summary
7.7.2 NAL Pharmaceuticals Ltd. Business Overview
7.7.3 NAL Pharmaceuticals Ltd. Neutropenia Drugs Major Product Offerings
7.4.4 NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.7.5 NAL Pharmaceuticals Ltd. Key News
7.8 Prolong Pharmaceuticals, LLC
7.8.1 Prolong Pharmaceuticals, LLC Corporate Summary
7.8.2 Prolong Pharmaceuticals, LLC Business Overview
7.8.3 Prolong Pharmaceuticals, LLC Neutropenia Drugs Major Product Offerings
7.8.4 Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Prolong Pharmaceuticals, LLC Key News
7.9 Richter Gedeon Nyrt.
7.9.1 Richter Gedeon Nyrt. Corporate Summary
7.9.2 Richter Gedeon Nyrt. Business Overview
7.9.3 Richter Gedeon Nyrt. Neutropenia Drugs Major Product Offerings
7.9.4 Richter Gedeon Nyrt. Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Richter Gedeon Nyrt. Key News
7.10 Sandoz International GmbH
7.10.1 Sandoz International GmbH Corporate Summary
7.10.2 Sandoz International GmbH Business Overview
7.10.3 Sandoz International GmbH Neutropenia Drugs Major Product Offerings
7.10.4 Sandoz International GmbH Neutropenia Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Sandoz International GmbH Key News
8 Global Neutropenia Drugs Production Capacity, Analysis
8.1 Global Neutropenia Drugs Production Capacity, 2016-2027
8.2 Neutropenia Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Neutropenia Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neutropenia Drugs Supply Chain Analysis
10.1 Neutropenia Drugs Industry Value Chain
10.2 Neutropenia Drugs Upstream Market
10.3 Neutropenia Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neutropenia Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Neutropenia Drugs in Global Market
Table 2. Top Neutropenia Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Neutropenia Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Neutropenia Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Neutropenia Drugs Sales by Companies, (K MT), 2016-2021
Table 6. Global Neutropenia Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Neutropenia Drugs Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Neutropenia Drugs Product Type
Table 9. List of Global Tier 1 Neutropenia Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neutropenia Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Apotex Inc.
Biogenomics Limited
Cellerant Therapeutics, Inc.
Coherus BioSciences, Inc.
Dr. Reddy's Laboratories Limited
Ligand Pharmaceuticals, Inc.
NAL Pharmaceuticals Ltd.
Prolong Pharmaceuticals, LLC
Richter Gedeon Nyrt.
Sandoz International GmbH

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE